MT1G and acute myeloid leukemia: Patricia et al. [25] showed that MT1 is critical for the growth and survival of DNMT3A;NPM1-mutant AML cells and nominated MT1 as a key marker for the treatment and prevention of DNMT3A;NPM1-mutant AML.